Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026, Mar 2026 and Apr 2026.
- Largest single sale: $932K (14,792 shares) of Arrowhead Pharmaceuticals, Inc. on Jan 5, 2026. Filing
- Last sale before this period: Oct 1, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief Medical Officer | Nov 2, 2020 | Apr 24, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Apr 23, 2026, Arrowhead Pharmaceuticals, Inc.: sold 10,000 shares for $750K, under a disclosed plan. 1 filing: 1
- Mar 5, 2026, Arrowhead Pharmaceuticals, Inc.: sold 10,000 shares for $642K, under a disclosed plan. 1 filing: 1
- Jan 6, 2026, Arrowhead Pharmaceuticals, Inc.: 75,000 shares granted. 1 filing: 1
- Jan 5, 2026, Arrowhead Pharmaceuticals, Inc.: sold 40,164 shares for $2.5M, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.